TRINETRA › Sectors › Healthcare
Vijaya Diagnostic Centre Limited (VIJAYA) — share price, P/E and fundamentals
Vijaya Diagnostic Centre Limited (NSE: VIJAYA) closed at ₹1,435.10 on 30 Oct 2026, +44.7% over one year, against a 52-week range of ₹848.00 – ₹1,593.60.
In the quarter ended 30 Jun 2026 (consolidated, filed 6 Aug 2026) it reported revenue of ₹231 cr and net profit of ₹53 cr, a 23.0% net margin; revenue grew 22.8% and profit grew 35.9% year on year.
On four consecutive filed quarters its trailing P/E is 78.8; since 12 May 2025 its own P/E has ranged from 55.4 to 86.2 (median 73.2), and today's reading is higher than 79% of those 364 trading days.
From the balance sheet dated 31 Mar 2026: return on equity 22.2%, ROCE 23.7%, debt-to-equity 0.00, Piotroski F-score 9 of 9.
Against 65 Healthcare peers on NSE: Net margin higher than 84% of 63 sector peers; PBT margin higher than 84% of 63 sector peers; ROE higher than 81% of 63 sector peers.
Key figures
| Last close | ₹1,435.10 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -6.0% / +34.7% / +44.7% |
| 52-week low – high | ₹848.00 – ₹1,593.60 |
| Market capitalisation | ₹14,767 cr |
| Trailing P/E | 78.8 |
| Price / book | 15.43 |
| EV / EBITDA | 38.3 |
| Earnings yield | 1.3% |
| TTM EPS | ₹18.22 |
| TTM net profit | ₹187 cr |
| Quarter revenue | ₹231 cr |
| Quarter net profit | ₹53 cr |
| Net margin | 23.0% |
| Revenue growth (YoY) | +22.8% |
| Profit growth (YoY) | +35.9% |
| Return on equity | 22.2% |
| ROCE | 23.7% |
| Debt / equity | 0.00 |
| Current ratio | 2.60 |
| Free cash flow | ₹88 cr |
| Piotroski F-score | 9 / 9 |
| Average daily turnover (50 days) | ₹15.4 cr |
Against Healthcare peers
| Metric | VIJAYA | Peer median | Percentile |
|---|---|---|---|
| Net margin | 22.99 | 12.67 | 84 |
| PBT margin | 30.71 | 17.57 | 84 |
| ROE | 22.19 | 13.86 | 81 |
| ROCE | 23.70 | 16.59 | 76 |
| Debt / equity | 0.00 | 0.11 | 12 |
| Cash conversion | 1.56 | 1.25 | 75 |
| Trailing P/E | 78.76 | 43.07 | 80 |
| P/B | 15.43 | 5.88 | 90 |
Questions
What is the P/E ratio of Vijaya Diagnostic Centre Limited?
Vijaya Diagnostic Centre Limited's trailing P/E is 78.8, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 12 May 2025 its P/E has ranged 55.4–86.2.
What were Vijaya Diagnostic Centre Limited's latest quarterly results?
For the quarter ended 30 Jun 2026, Vijaya Diagnostic Centre Limited reported revenue of ₹231 cr and net profit of ₹53 cr (consolidated), filed with the exchange on 6 Aug 2026.
What is Vijaya Diagnostic Centre Limited's ROE?
Return on equity is 22.2% based on the balance sheet dated 31 Mar 2026.
Does Vijaya Diagnostic Centre Limited have debt?
Debt-to-equity is 0.00 on the balance sheet dated 31 Mar 2026.
What is VIJAYA's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, VIJAYA traded between ₹848.00 and ₹1,593.60.
Other Healthcare stocks
- Sun Pharmaceutical Industries Limited (SUNPHARMA)
- Divi's Laboratories Limited (DIVISLAB)
- Torrent Pharmaceuticals Limited (TORNTPHARM)
- Laurus Labs Limited (LAURUSLABS)
- Zydus Lifesciences Limited (ZYDUSLIFE)
- Apollo Hospitals Enterprise Limited (APOLLOHOSP)
- Dr. Reddy's Laboratories Limited (DRREDDY)
- Cipla Limited (CIPLA)
- Mankind Pharma Limited (MANKIND)
- Aurobindo Pharma Limited (AUROPHARMA)
- Lupin Limited (LUPIN)
- Max Healthcare Institute Limited (MAXHEALTH)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.